source
- AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicineNewly published data convinced AstraZeneca to conduct a sprawling late-stage program for its GLP-1 pill. Elsewhere, Bausch + Lomb will lay off 119 employees and Cartesian boosted its ‘in vivo’ cell…BioPharma Dive · 1mo ago↗ source
- DOJ reaches second settlement on youth gender careA new era of American sunscreen, NIAID taps new acting director, and more health news from Morning RoundsSTAT · 1mo ago↗ source
- Ethyreal lands $101M to treat both Graves' and thyroid eye diseaseA biotech backed by Atlas Venture and Medicxi uncloaked on Wednesday morning to tackle the related autoimmune conditions Graves' disease and thyroid eye disease, and the startup plans to enter the…